Therapeutic approaches targeting the gut microbiota in ischemic stroke: current advances and future directions.

IF 2.5 Q3 MICROBIOLOGY Bioscience of microbiota, food and health Pub Date : 2024-01-01 Epub Date: 2024-07-18 DOI:10.12938/bmfh.2024-022
Zhiguo Mao, Jinying Zhang, Lin Guo, Xiaoran Wang, Zhengwang Zhu, Mingsan Miao
{"title":"Therapeutic approaches targeting the gut microbiota in ischemic stroke: current advances and future directions.","authors":"Zhiguo Mao, Jinying Zhang, Lin Guo, Xiaoran Wang, Zhengwang Zhu, Mingsan Miao","doi":"10.12938/bmfh.2024-022","DOIUrl":null,"url":null,"abstract":"<p><p>Ischemic stroke (IS) is the predominant form of stroke pathology, and its clinical management remains constrained by therapeutic time frame. The gut microbiota (GM), comprising a multitude of bacterial and archaeal cells, surpasses the human cell count by approximately tenfold and significantly contributes to the human organism's growth, development, and overall well-being. The microbiota-gut-brain axis (MGBA) in recent years has established a strong association between gut microbes and the brain, demonstrating their intricate involvement in the progression of IS. The regulation of IS by the GM, encompassing changes in composition, abundance, and distribution, is multifaceted, involving neurological, endocrine, immunological, and metabolic mechanisms. This comprehensive understanding offers novel insights into the therapeutic approaches for IS. The objective of this paper is to examine the mechanisms of interaction between the GM and IS in recent years, assess the therapeutic effects of the GM on IS through various interventions, such as dietary modifications, probiotics, fecal microbiota transplantation, and antibiotics, and offer insights into the potential clinical application of the GM in stroke treatment.</p>","PeriodicalId":93908,"journal":{"name":"Bioscience of microbiota, food and health","volume":"43 4","pages":"321-328"},"PeriodicalIF":2.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444859/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioscience of microbiota, food and health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12938/bmfh.2024-022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Ischemic stroke (IS) is the predominant form of stroke pathology, and its clinical management remains constrained by therapeutic time frame. The gut microbiota (GM), comprising a multitude of bacterial and archaeal cells, surpasses the human cell count by approximately tenfold and significantly contributes to the human organism's growth, development, and overall well-being. The microbiota-gut-brain axis (MGBA) in recent years has established a strong association between gut microbes and the brain, demonstrating their intricate involvement in the progression of IS. The regulation of IS by the GM, encompassing changes in composition, abundance, and distribution, is multifaceted, involving neurological, endocrine, immunological, and metabolic mechanisms. This comprehensive understanding offers novel insights into the therapeutic approaches for IS. The objective of this paper is to examine the mechanisms of interaction between the GM and IS in recent years, assess the therapeutic effects of the GM on IS through various interventions, such as dietary modifications, probiotics, fecal microbiota transplantation, and antibiotics, and offer insights into the potential clinical application of the GM in stroke treatment.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
针对缺血性中风的肠道微生物群的治疗方法:当前进展与未来方向。
缺血性中风(IS)是中风的主要病理形式,其临床治疗仍然受到治疗时限的限制。肠道微生物群(GM)由大量细菌和古细菌细胞组成,其数量约为人体细胞数量的十倍,对人类机体的生长、发育和整体健康做出了重要贡献。近年来,微生物群-肠道-大脑轴(MGBA)建立了肠道微生物与大脑之间的紧密联系,证明它们在 IS 的发展过程中有着错综复杂的参与。肠道微生物群对 IS 的调控包括组成、丰度和分布的变化,是多方面的,涉及神经、内分泌、免疫和代谢机制。这种全面的认识为 IS 的治疗方法提供了新的视角。本文旨在研究近年来转基因与 IS 之间的相互作用机制,评估转基因通过各种干预措施(如饮食调整、益生菌、粪便微生物群移植和抗生素)对 IS 的治疗效果,并就转基因在中风治疗中的潜在临床应用提供见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.20
自引率
0.00%
发文量
0
期刊最新文献
Transcriptional profiling of geniposide bioconversion into genipin during gardenia fructus extract fermentation by Lactobacillus (Lactiplantibacillus) plantarum SN13T. Development of an improved colonization system for human-derived Bifidobacterium longum subsp. longum in conventional mice through the feeding of raffinose or 1-kestose. Efficacy and safety of rifaximin in patients with chronic intestinal pseudo-obstruction: a randomized, double-blind, placebo-controlled, phase II-a exploratory trial. Genome-based assessment of safety characteristics of Lacticaseibacillus paracasei NY1301 and genomic differences in closely related strains marketed as probiotics. Immunomodulatory effects of Ulva-derived polysaccharides, oligosaccharides, and residues in a murine model of delayed-type hypersensitivity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1